Antiphospholipid Syndrome – Anticoagulation — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Warfarin with target INR 2.5
Explanation lettering: E = shown as A · A = shown as B · D = shown as C · C = shown as D · B = shown as E
In antiphospholipid syndrome with arterial thrombosis, warfarin is the recommended long-term anticoagulant. DOACs are NOT recommended — the TRAPS trial showed increased thrombotic events with rivaroxaban compared to warfarin in triple-positive APS. A: Aspirin alone is insufficient for APS with arterial thrombosis. C/D/E: DOACs are inferior to warfarin in APS.
Reference: EULAR/ACR APS Guidelines (2019); TRAPS Trial (2018)